Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Ewing Sarcoma
Regimen:
VAIA (dactinomycin + doxorubicin hydrochloride + ifosfamide + vincristine)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
09/28/2022
Excerpt:
Ewing Sarcoma…Other Recommended Regimens...VAIA (vincristine, doxorubicin, ifosfamide, and dactinomycin)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login